Kai Chen1, Rong Mou1, Pengwei Zhu1

  • 1Departments of Cardiology (K.C., R.M., P.Z., X.X., L.J., Y.H., X.H., Qingbo Xu), the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Circulation
|December 14, 2022
PubMed
概括

淋巴细胞发生,新淋巴血管的形成,驱动心脏移植后的动脉样硬化. 通过抑制淋巴血管生成,抑制血管内皮生长因子C (VEGF-C) 可以预防这种并发症.